vorinostat has been researched along with Proteinuria in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reilly, CM | 1 |
| Mishra, N | 1 |
| Miller, JM | 1 |
| Joshi, D | 1 |
| Ruiz, P | 1 |
| Richon, VM | 1 |
| Marks, PA | 1 |
| Gilkeson, GS | 1 |
1 other study available for vorinostat and Proteinuria
| Article | Year |
|---|---|
Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
Topics: Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoantibodies; CD3 Comple | 2004 |